Visage Imaging receives US clearance for medical imaging software
6 January 2009
Visage Imaging, Inc., a wholly owned subsidiary of Mercury Computer
Systems, Inc. (NASDAQ: MRCY), announced that it has received FDA 510(k)
clearance to market its latest thin-client product release, Visage CS
3.1. This release brings significant enhancements to its prior offerings
in cardiac and other tools, and includes new optional neuroradiology and
oncology applications.
The neuro option facilitates brain perfusion analysis in CT and MRI
imaging, while the oncology option provides tools for analyzing,
documenting, and comparing lesions for multiple modalities, including
standardized update value (SUV)-based analysis for PET-CT.
“Visage Imaging’s thin-client solution instantly brings
workstation-class diagnostic tools to the numerous workplaces of those
who need them,” said Hartmut Schirmacher, Director of Product Management
for Visage Imaging.
“Compared to typical workstations or other web-based ‘fat’ solutions,
Visage CS offers far superior performance across the board, especially
when viewing and processing large data volumes. Furthermore, Visage CS
3.1 will affordably allow for broader access to state-of-the-art
applications throughout the enterprise.”
In addition to the new application options, Visage CS 3.1 features
new and streamlined measurement and post-processing tools such as
advanced 3D segmentation, ROI-based analysis and time-value curves, and
improved editing of cardiac LV models.
Bookmark this page